These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


285 related items for PubMed ID: 3481871

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. CD8+ poikilodermatous mycosis fungoides with a nonaggressive clinical behaviour and a good response to psoralen plus ultraviolet A treatment.
    Ada S, Güleç AT.
    Br J Dermatol; 2007 Nov; 157(5):1064-6. PubMed ID: 17854364
    [No Abstract] [Full Text] [Related]

  • 3. Development of new lesions: a complication of psoralen plus ultraviolet A light therapy for mycosis fungoides.
    Fernandes S, Marques Pinto G, Cardoso J.
    Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):278-9. PubMed ID: 22971198
    [No Abstract] [Full Text] [Related]

  • 4. Photochemotherapy (PUVA) in the pretumour stage of mycosis fungoides: a report from the Scandinavian Mycosis Fungoides Study Group.
    Molin L, Thomsen K, Volden G, Groth O.
    Acta Derm Venereol; 1981 Oct; 61(1):47-51. PubMed ID: 6164214
    [Abstract] [Full Text] [Related]

  • 5. Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA.
    Mostow EN, Neckel SL, Oberhelman L, Anderson TF, Cooper KD.
    Arch Dermatol; 1993 Jun; 129(6):747-52. PubMed ID: 8507078
    [Abstract] [Full Text] [Related]

  • 6. Retinoids plus PUVA (RePUVA) and PUVA in mycosis fungoides, plaque stage. A report from the Scandinavian Mycosis Fungoides Group.
    Thomsen K, Hammar H, Molin L, Volden G.
    Acta Derm Venereol; 1989 Jun; 69(6):536-8. PubMed ID: 2575334
    [Abstract] [Full Text] [Related]

  • 7. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).
    Soung J, Muigai W, Amin N, Stern DK, Lebwohl MG.
    J Drugs Dermatol; 2005 Jun; 4(3):290-4. PubMed ID: 15898283
    [Abstract] [Full Text] [Related]

  • 8. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
    Ahmad K, Rogers S, McNicholas PD, Collins P.
    Acta Derm Venereol; 2007 Jun; 87(5):413-7. PubMed ID: 17721648
    [Abstract] [Full Text] [Related]

  • 9. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
    Weber F, Schmuth M, Sepp N, Fritsch P.
    Acta Derm Venereol; 2005 Jun; 85(4):329-32. PubMed ID: 16191854
    [Abstract] [Full Text] [Related]

  • 10. Conjunctival involvement with mycosis fungoides in a patient receiving PUVA therapy.
    O'Day J, Rotstein H, Weiner JM.
    Ophthalmology; 1985 Jan; 92(1):109-13. PubMed ID: 3974989
    [Abstract] [Full Text] [Related]

  • 11. [Results of photochemotherapy in a series of 47 patients with mycosis fungoides].
    Piccinno R, Caccialanza M, Mainardi L.
    G Ital Dermatol Venereol; 1989 Jan; 124(7-8):369-73. PubMed ID: 2628282
    [Abstract] [Full Text] [Related]

  • 12. Hyperpigmented mycosis fungoides: a case report.
    Erbil H, Sezer E, Koseoglu D, Filiz N, Kurumlu Z, Bülent Taştan H, Demiriz M.
    J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):982-3. PubMed ID: 17659014
    [No Abstract] [Full Text] [Related]

  • 13. [Change of level of mycosis fungoides under systemic PUVA-therapy (author's transl)].
    Tourbier H, Schultz-Ehrenburg U.
    Z Hautkr; 1981 Jul 15; 56(14):923-9. PubMed ID: 7269717
    [Abstract] [Full Text] [Related]

  • 14. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M, García-Arpa M, González-García J.
    Int J Dermatol; 2007 Jan 15; 46(1):99-102. PubMed ID: 17214731
    [Abstract] [Full Text] [Related]

  • 15. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.
    Coors EA, Von den Driesch P.
    Br J Dermatol; 2005 Jun 15; 152(6):1379-81. PubMed ID: 15949024
    [No Abstract] [Full Text] [Related]

  • 16. PUVA in early mycosis fungoides may give long-term remission and delay extracutaneous spread.
    Roupe G, Sandström MH, Kjellström C.
    Acta Derm Venereol; 1996 Nov 15; 76(6):475-8. PubMed ID: 8982416
    [Abstract] [Full Text] [Related]

  • 17. Topical bexarotene for psoralen plus ultraviolet A-induced photodamage.
    Deonizio JM, Vaghani SP, Guitart J.
    J Am Acad Dermatol; 2013 Aug 15; 69(2):e96-8. PubMed ID: 23866897
    [No Abstract] [Full Text] [Related]

  • 18. Treatment of Early Folliculotropic Mycosis Fungoides with Special Focus on Psoralen plus Ultraviolet A.
    Amitay-Laish I, Prag-Naveh H, Dalal A, Pavlovsky L, Feinmesser M, Hodak E.
    Acta Derm Venereol; 2018 Nov 05; 98(10):951-955. PubMed ID: 30085321
    [Abstract] [Full Text] [Related]

  • 19. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A, Hofer A, Legat F, Kerl H, Wolf P.
    Br J Dermatol; 2006 Mar 05; 154(3):519-23. PubMed ID: 16445785
    [Abstract] [Full Text] [Related]

  • 20. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
    Wozniak MB, Tracey L, Ortiz-Romero PL, Montes S, Alvarez M, Fraga J, Fernández Herrera J, Vidal S, Rodriguez-Peralto JL, Piris MA, Villuendas Deceased R.
    Br J Dermatol; 2009 Jan 05; 160(1):92-102. PubMed ID: 18945306
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.